|
SMPD4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.214950E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.128000E-02 |
| Normal-vs-Stage2 |
7.457600E-02 |
| Normal-vs-Stage3 |
8.099300E-03 |
| Normal-vs-Stage4 |
3.901900E-02 |
| Stage1-vs-Stage2 |
6.235400E-01 |
| Stage1-vs-Stage3 |
1.187580E-01 |
| Stage1-vs-Stage4 |
1.031440E-01 |
| Stage2-vs-Stage3 |
3.748000E-01 |
| Stage2-vs-Stage4 |
3.328800E-01 |
| Stage3-vs-Stage4 |
8.810800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.983000E-04 |
| Normal-vs-AfricanAmerican |
7.676600E-03 |
| Normal-vs-Asian |
2.762000E-01 |
| Caucasian-vs-AfricanAmerican |
8.633400E-01 |
| Caucasian-vs-Asian |
8.098600E-01 |
| AfricanAmerican-vs-Asian |
8.838000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.635700E-04 |
| Normal-vs-Female |
2.815900E-04 |
| Male-vs-Female |
2.276000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.734300E-02 |
| Normal-vs-Extreme_Weight |
1.604100E-02 |
| Normal-vs-Obese |
8.406500E-04 |
| Normal-vs-Extreme_Obese |
3.922200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.617200E-01 |
| Normal_Weight-vs-Obese |
1.010410E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.842000E-01 |
| Extreme_Weight-vs-Obese |
1.318430E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.561800E-01 |
| Obese-vs-Extreme_Obese |
4.052800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.83039999946244E-07 |
| Normal-vs-Age(41-60Yrs) |
3.20090000005546E-06 |
| Normal-vs-Age(61-80Yrs) |
2.666100E-02 |
| Normal-vs-Age(81-100Yrs) |
6.116000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.054560E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.675700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.833880E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.580000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.153970E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.899200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.07850000000231E-06 |
| Normal-VS-Type2 PRCC |
8.148000E-01 |
| Normal-VS-KIRP CIMP |
4.039900E-03 |
| Normal-VS-Unclassified PRCC |
6.458400E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.63920000000517E-05 |
| Type1 PRCC-VS-KIRP CIMP |
1.890500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.411200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.819100E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.016240E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.799700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.739840E-01 |
| Normal-vs-N1 |
2.176500E-03 |
| Normal-vs-N2 |
1.74440000000331E-06 |
| N0-vs-N1 |
1.344430E-02 |
| N0-vs-N2 |
1.964340E-03 |
| N1-vs-N2 |
4.435200E-01 |
|
|
